Journal of Medicinal Chemistry
Article
(6) Vandenbroucke, R. E.; Dejonckheere, E.; Van Hauwermeiren, F.;
Lodens, S.; De Rycke, R.; Van Wonterghem, E.; Staes, A.; Gevaert, K.;
(21) Thiel, K. A. Structure-aided drug design’s next generation. Nat.
Biotechnol. 2004, 22, 513−519.
(22) Sliwoski, G.; Kothiwale, S.; Meiler, J.; Lowe, E. W. Computa-
tional methods in drug discovery. Pharmacol. Rev. 2014, 66, 334−395.
(23) Kuntz, I. D. Structure-based strategies for drug design and
discovery. Science 1992, 257, 1078−1082.
(24) Spicer, T. P.; Jiang, J. W.; Taylor, A. B.; Choi, J. Y.; Hart, P. J.;
Roush, W. R.; Fields, G. B.; Hodder, P. S.; Minond, D. Character-
ization of selective exosite-binding inhibitors of matrix metal-
loproteinase 13 that prevent articular cartilage degradation in vitro. J.
Med. Chem. 2014, 57, 9598−9611.
(25) Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.
N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The protein data bank.
Nucleic Acids Res. 2000, 28, 235−242.
(26) Wu, J.; Rush, T. S., III; Hotchandani, R.; Du, X.; Geck, M.;
Collins, E.; Xu, Z.-B.; Skotnicki, J.; Levin, J. I.; Lovering, F. E.
Identification of potent and selective MMP-13 inhibitors. Bioorg. Med.
Chem. Lett. 2005, 15, 4105−4109.
(27) Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.;
Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.;
Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: A new
approach for rapid, accurate docking and scoring. 1. Method and
assessment of docking accuracy. J. Med. Chem. 2004, 47, 1739−1749.
(28) Halgren, T. A.; Murphy, R. B.; Friesner, R. A.; Beard, H. S.;
Frye, L. L.; Pollard, W. T.; Banks, J. L. Glide:- A new approach for
rapid, accurate docking and scoring. 2. Enrichment factors in database
screening. J. Med. Chem. 2004, 47, 1750−1759.
Lop
́
ez-Otin, C.; Libert, C. Matrix metalloproteinase 13 modulates
intestinal epithelial barrier integrity in inflammatory diseases by
activating TNF. EMBO Mol. Med. 2013, 5, 1000−1016.
(7) Zigrino, P.; Kuhn, I.; Bauerle, T.; Zamek, J.; Fox, J. W.;
Neumann, S.; Licht, A.; Schorpp-Kistner, M.; Angel, P.; Mauch, C.
Stromal expression of MMP-13 is required for melanoma invasion and
metastasis. J. Invest. Dermatol. 2009, 129, 2686−2693.
(8) Lukacova, V.; Zhang, Y.; Mackov, M.; Baricic, P.; Raha, S.; Calvo,
J. A.; Balaz, S. Similarity of binding sites of human matrix
metalloproteinases. J. Biol. Chem. 2004, 279, 14194−14200.
(9) Lovejoy, B.; Welch, A. R.; Carr, S.; Luong, C.; Broka, C.;
Hendricks, R. T.; Campbell, J. A.; Walker, K. A. M.; Martin, R.; Van
Wart, H.; Browner, M. F. Crystal structures of MMP-1 and −13 reveal
the structural basis for selectivity of collagenase inhibitors. Nat. Struct.
Biol. 1999, 6, 217−221.
(10) Rothenberg, M. L.; Nelson, A. R.; Hande, K. R. New drugs on
the horizon: matrix metalloproteinase inhibitors. Stem Cells 1999, 17,
237−240.
(11) Blagg, J. A.; Noe, M. C.; Wolf-Gouveia, L. A.; Reiter, L. A.;
Laird, E. R.; Chang, S.-P. P.; Danley, D. E.; Downs, J. T.; Elliott, N. C.;
Eskra, J. D.; Griffiths, R. J.; Hardink, J. R.; Haugeto, A. I.; Jones, C. S.;
Liras, J. L.; Lopresti-Morrow, L. L.; Mitchell, P. G.; Pandit, J.;
Robinson, R. P.; Subramanyam, C.; Vaughn-Bowser, M. L.; Yocum, S.
A. Potent pyrimidinetrione-based inhibitors of MMP-13 with
enhanced selectivity over MMP-14. Bioorg. Med. Chem. Lett. 2005,
15, 1807−1810.
(29) Roth, J.; Minond, D.; Darout, E.; Liu, Q.; Lauer, J.; Hodder, P.;
Fields, G. B.; Roush, W. R. Identification of novel, exosite-binding
matrix metalloproteinase-13 inhibitor scaffolds. Bioorg. Med. Chem.
Lett. 2011, 21, 7180−7184.
(12) Mengshol, J. A.; Mix, K. S.; Brinckerhoff, C. E. Matrix
metalloproteinases as therapeutic targets in arthritic diseases: bull’s-eye
or missing the mark? Arthritis Rheum. 2002, 46, 13−20.
(13) Burrage, P. S.; Mix, K. S.; Brinckerhoff, C. E. Matrix
metalloproteinases: role in arthritis. Front. Biosci., Landmark Ed.
2006, 11, 529−543.
(30) Lauer-Fields, J. L.; Fields, G. B. Triple-helical peptide analysis of
collagenolytic protease activity. Biol. Chem. 2002, 383, 1095−1105.
(31) Minond, D.; Lauer-Fields, J. L.; Cudic, M.; Overall, C. M.; Pei,
D. Q.; Brew, K.; Visse, R.; Nagase, H.; Fields, G. B. The roles of
substrate thermal stability and P2 and P1′ subsite identity on matrix
metalloproteinase triple-helical peptidase activity and collagen
specificity. J. Biol. Chem. 2006, 281, 38302−38313.
(14) Fingleton, B. MMPs as therapeutic targetsstill a viable option?
Semin. Cell Dev. Biol. 2008, 19, 61−68.
(15) Nara, H.; Kaieda, A.; Sato, K.; Naito, T.; Mototani, H.; Oki, H.;
Yamamoto, Y.; Kuno, H.; Santou, T.; Kanzaki, N.; Terauchi, J.;
Uchikawa, O.; Kori, M. Discovery of novel, highly potent, and selective
matrix metalloproteinase (MMP)-13 inhibitors with a 1,2,4-triazol-3-yl
moiety as a zinc binding group using a structure-based design
approach. J. Med. Chem. 2017, 60, 608−626.
(32) Parks, W. C.; Wilson, C. L.; Lopez-Boado, Y. S. Matrix
metalloproteinases as modulators of inflammation and innate
immunity. Nat. Rev. Immunol. 2004, 4, 617−629.
(33) Bigg, H. F.; Rowan, A. D.; Barker, M. D.; Cawston, T. E.
Activity of matrix metalloproteinase-9 against native collagen types I
and III. FEBS J. 2007, 274, 1246−1255.
(16) Dorman
Kovacs, L.; Ferdinandy, P. Matrix metalloproteinase inhibitors. Drugs
́
́ ́
, G.; Cseh, S.; Hajdu, I.; Barna, L.; Konya, D.; Kupai, K.;
́
2010, 70, 949−964.
(34) Fields, G. B. Interstitial collagen catabolism. J. Biol. Chem. 2013,
288, 8785−8793.
(17) Nara, H.; Sato, K.; Naito, T.; Mototani, H.; Oki, H.; Yamamoto,
Y.; Kuno, H.; Santou, T.; Kanzaki, N.; Terauchi, J.; Uchikawa, O.;
Kori, M. Discovery of novel, highly potent, and selective quinazoline-2-
carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors
without a zinc binding group using a structure-based design approach.
J. Med. Chem. 2014, 57, 8886−8902.
(35) Lauer-Fields, J. L.; Broder, T.; Sritharan, T.; Chung, L.; Nagase,
H.; Fields, G. B. Kinetic analysis of matrix metalloproteinase activity
using fluorogenic triple-helical substrates. Biochemistry 2001, 40,
5795−5803.
(36) Overall, C. M.; Kleifeld, O. Towards third generation matrix
metalloproteinase inhibitors for cancer therapy. Br. J. Cancer 2006, 94,
941−946.
(18) Gege, C.; Bao, B.; Bluhm, H.; Boer, J.; Gallagher, B. M.;
Korniski, B.; Powers, T. S.; Steeneck, C.; Taveras, A. G.; Baragi, V. M.
Discovery and evaluation of a non-Zn chelating, selective matrix
metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular
treatment of osteoarthritis. J. Med. Chem. 2012, 55, 709−716.
(19) Johnson, A. R.; Pavlovsky, A. G.; Ortwine, D. F.; Prior, F.; Man,
C. F.; Bornemeier, D. A.; Banotai, C. A.; Mueller, W. T.; Mcconnell,
P.; Yan, C.; Baragi, V.; Lesch, C.; Roark, W. H.; Wilson, M.; Datta, K.;
Guzman, R.; Han, H. K.; Dyer, R. D. Discovery and characterization of
a novel inhibitor of matrix metalloprotease-13 that reduces cartilage
damage in vivo without joint fibroplasia side effects. J. Biol. Chem.
2007, 282, 27781−27791.
(37) Heim-Riether, A.; Taylor, S. J.; Liang, S.; Gao, D. A.; Xiong, Z.;
August, E. M.; Collins, B. K.; Farmer, B. T., II; Haverty, K.; Hill-
Drzewi, M.; Junker, H.-D.; Margarit, S. M.; Moss, N.; Neumann, T.;
Proudfoot, J. R.; Smith Keenan, L.; Sekul, R.; Zhang, Q.; Li, J.; Farrow,
N. A. Improving potency and selectivity of a new class of non-Zn-
chelating MMP-13 inhibitors. Bioorg. Med. Chem. Lett. 2009, 19,
5321−5324.
(38) Miyaura, N.; Suzuki, A. Palladium-catalyzed cross-coupling
reactions of organoboron compounds. Chem. Rev. 1995, 95, 2457−
2483.
(20) Nara, H.; Sato, K.; Kaieda, A.; Oki, H.; Kuno, H.; Santou, T.;
Kanzaki, N.; Terauchi, J.; Uchikawa, O.; Kori, M. Design, synthesis,
and biological activity of novel, potent, and highly selective fused
pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase
(MMP)-13 zinc-binding inhibitors. Bioorg. Med. Chem. 2016, 24,
6149−6165.
(39) Chung, L.; Dinakarpandian, D.; Yoshida, N.; Lauer-Fields, J. L.;
Fields, G. B.; Visse, R.; Nagase, H. Collagenase unwinds triple-helical
collagen prior to peptide bond hydrolysis. EMBO J. 2004, 23, 3020−
3030.
(40) Neumann, U.; Kubota, H.; Frei, K.; Ganu, V.; Leppert, D.
Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a
I
J. Med. Chem. XXXX, XXX, XXX−XXX